Works in Clinical Lymphoma, Myeloma & Leukemia, 2021, Vol 21
Results: 1385
Table of Contents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. A9, doi. 10.1016/S2152-2650(21)02434-4
- Publication type:
- Article
Editorial Board.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. A4, doi. 10.1016/S2152-2650(21)02433-2
- Publication type:
- Article
IVAC With or Without Rituximab for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas: Real-World Experience in the Modern Era.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Primary Cutaneous B-Cell Lymphomas in Children and Adolescents: A SEER Population-Based Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. e1000, doi. 10.1016/j.clml.2021.07.021
- By:
- Publication type:
- Article
Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. e985, doi. 10.1016/j.clml.2021.07.022
- By:
- Publication type:
- Article
A Phase 2 Study of PNT2258 for Treatment of Relapsed or Refractory B-Cell Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. 823, doi. 10.1016/j.clml.2021.07.016
- By:
- Publication type:
- Article
Optimal Supportive Care With Selinexor Improves Outcomes in Patients With Relapsed/Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. e975, doi. 10.1016/j.clml.2021.07.014
- By:
- Publication type:
- Article
Dealing With High-Risk AL Amyloidosis Patients: A Single Hematologic Center Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. e970, doi. 10.1016/j.clml.2021.07.015
- By:
- Publication type:
- Article
Special Considerations for Supportive Care and Management of Complications in Elderly Patients With Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. 812, doi. 10.1016/j.clml.2021.07.013
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions: The Past, Present and Future of Venetoclax-Based Therapies in AML.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. 805, doi. 10.1016/j.clml.2021.07.012
- By:
- Publication type:
- Article
Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. 831, doi. 10.1016/j.clml.2021.07.010
- By:
- Publication type:
- Article
Prognostic Impact of Concurrent DNMT3A, FLT3 and NPM1 Gene Mutations in Acute Myeloid Leukemia Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. e960, doi. 10.1016/j.clml.2021.07.011
- By:
- Publication type:
- Article
The Real-Life Efficacy of Fixed-Dose Hypomethylating Agents in Older Patients With Acute Myeloid Leukemia: A 10-Year Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. 852, doi. 10.1016/j.clml.2021.07.008
- By:
- Publication type:
- Article
Molecular Characterization and Clinical Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Patients With TP53 Mutation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. 841, doi. 10.1016/j.clml.2021.07.007
- By:
- Publication type:
- Article
Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome in a Patient With Heterozygous CFHR3/CFHR1 Deletion Treated With Eculizumab.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e845, doi. 10.1016/j.clml.2021.06.019
- By:
- Publication type:
- Article
Ninety-Minute Daratumumab Infusions for Relapsed and Refractory Multiple Myeloma: Two Years of Italian Single-Center Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e850, doi. 10.1016/j.clml.2021.06.018
- By:
- Publication type:
- Article
A Case of Bing-Neel Syndrome Treated Successfully With Ibrutinib Monotherapy Following Intensive Chemoimmunotherapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e817, doi. 10.1016/j.clml.2021.06.017
- By:
- Publication type:
- Article
Outcomes Related to FDG-PET-CT Response in Patients With Hodgkin Lymphoma Treated With Brentuximab-Vedotin at Relapse or Consolidation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. e929, doi. 10.1016/j.clml.2021.07.006
- By:
- Publication type:
- Article
Diffuse Large B Cell Lymphoma in Patients 80 Years and Older: Worse Survival After Treatment Without Increased Relapse Rates.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 799, doi. 10.1016/j.clml.2021.06.015
- By:
- Publication type:
- Article
Repertoire of Rearranged Immunoglobulin Heavy Chain Genes in Russian Patients With B-Cell Lymphoproliferative Diseases.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. e938, doi. 10.1016/j.clml.2021.07.005
- By:
- Publication type:
- Article
Light Chain Amyloidosis (AL) Associated With B Cell Lymphoma a Single Center Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. e946, doi. 10.1016/j.clml.2021.07.003
- By:
- Publication type:
- Article
Real-World Experience of Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed or Refractory Aggressive B-cell Lymphomas: A Single-Institution Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 12, p. 861, doi. 10.1016/j.clml.2021.07.002
- By:
- Publication type:
- Article
Table of Contents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. A7, doi. 10.1016/S2152-2650(21)02378-8
- Publication type:
- Article
A Phase II Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 775, doi. 10.1016/j.clml.2021.07.029
- By:
- Publication type:
- Article
Editorial Board.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. A5, doi. 10.1016/S2152-2650(21)02377-6
- Publication type:
- Article
Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e853, doi. 10.1016/j.clml.2021.07.025
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 725, doi. 10.1016/j.clml.2021.07.009
- By:
- Publication type:
- Article
Accurate Machine-Learning-Based classification of Leukemia from Blood Smear Images.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e903, doi. 10.1016/j.clml.2021.06.025
- By:
- Publication type:
- Article
Long-Term Outcome of Philadelphia Chromosome Positive Leukemia From Eastern Indian Subcontinent: An Experience in the Era of Tyrosine Kinase Inhibitor (TKI) Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e876, doi. 10.1016/j.clml.2021.06.026
- By:
- Publication type:
- Article
Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e915, doi. 10.1016/j.clml.2021.06.023
- By:
- Publication type:
- Article
Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e895, doi. 10.1016/j.clml.2021.06.022
- By:
- Publication type:
- Article
Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e886, doi. 10.1016/j.clml.2021.06.021
- By:
- Publication type:
- Article
Panobinostat From Bench to Bedside: Rethinking the Treatment Paradigm for Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 752, doi. 10.1016/j.clml.2021.06.020
- By:
- Publication type:
- Article
Risk of Non-Hodgkin's Lymphoma in HCV Patients in the United States Between 2013 and 2020: A Population-Based Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e832, doi. 10.1016/j.clml.2021.06.014
- By:
- Publication type:
- Article
Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas—Retrospective and Multicentric Analysis of Portuguese Centers.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e839, doi. 10.1016/j.clml.2021.06.013
- By:
- Publication type:
- Article
Primary Mediastinal B-Cell Lymphoma: A 2021 Update on Genetics, Diagnosis, and Novel Therapeutics.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e865, doi. 10.1016/j.clml.2021.06.012
- By:
- Publication type:
- Article
The Role of Interim PET/CT on Survival in Diffuse Large B Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e922, doi. 10.1016/j.clml.2021.06.016
- By:
- Publication type:
- Article
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparative Efficacy of First-Line Treatments of Chronic Lymphocytic Leukemia: Network Meta-Analyses of Survival Curves.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e820, doi. 10.1016/j.clml.2021.06.010
- By:
- Publication type:
- Article
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 785, doi. 10.1016/j.clml.2021.06.005
- By:
- Publication type:
- Article
Emerging Targets and Cellular Therapy for Relapsed Refractory Multiple Myeloma: A Systematic Review.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 741, doi. 10.1016/j.clml.2021.06.003
- By:
- Publication type:
- Article
Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 734, doi. 10.1016/j.clml.2021.05.018
- By:
- Publication type:
- Article
Author Abstract Index.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S172, doi. 10.1016/S2152-2650(21)02368-5
- Publication type:
- Article
NP-114: Lesson Learned: Management of patients with Multiple Myeloma (MM) and their response to two doses of COVID-19 RNA vaccine.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S171, doi. 10.1016/S2152-2650(21)02367-3
- By:
- Publication type:
- Article
NP-113: Developing a national information and support group program for the carers of people living with myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S170, doi. 10.1016/S2152-2650(21)02366-1
- By:
- Publication type:
- Article
NP-112: Onboarding advanced practice providers to myeloma clinical teams.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S170, doi. 10.1016/S2152-2650(21)02365-X
- By:
- Publication type:
- Article
NP-111: Myeloma Treatment Scheduler (MyeTxScheduler): an online educational tool to help keep patients on track.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S170, doi. 10.1016/S2152-2650(21)02364-8
- By:
- Publication type:
- Article
NP-110: Physical activity in multiple myeloma: a review of the literature.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S169, doi. 10.1016/S2152-2650(21)02363-6
- By:
- Publication type:
- Article
NP-109: Improving long-term quality of life for patients living with multiple myeloma: a service evaluation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S169, doi. 10.1016/S2152-2650(21)02362-4
- By:
- Publication type:
- Article
NP-108: Improvement in patient experience with successful implementation of a Velcade at Home program in patients with myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S168, doi. 10.1016/S2152-2650(21)02361-2
- By:
- Publication type:
- Article